Beranda › Kanker Testis
Uji klinis Kanker Testis yang merekrut di AS
18 studi untuk Kanker Testis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY5 studi
- Nashville, TN4 studi
- Durham, NC4 studi
- Birmingham, AL3 studi
- Dallas, TX3 studi
- Indianapolis, IN3 studi
- Edison, NJ3 studi
- Omaha, NE3 studi
- Atlanta, GA3 studi
- Baldwin Park, CA3 studi
Berdasarkan negara bagian
- Alabama3 studi
- Arizona4 studi
- California8 studi
- Colorado4 studi
- Florida4 studi
- Georgia3 studi
- Illinois4 studi
- Indiana4 studi
- Massachusetts3 studi
- Minnesota3 studi
- Nebraska3 studi
- New Jersey4 studi
- New York6 studi
- North Carolina6 studi
- Ohio4 studi
- Pennsylvania3 studi
- Tennessee4 studi
- Texas3 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06515613Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06276491MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial
Menerima pesertaStudi observasional
Usia 18 ke atas · Pria · Diperbarui 20 Agu 2026 · NCT06060873Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Pria · Diperbarui 27 Jul 2026 · NCT05611307A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06866964Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 10 Jul 2026 · NCT06828185Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Menerima peserta
Usia 21 hingga 45 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07406087Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT07407582Brodalumab in the Treatment of Immune-Related Adverse Events
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06673329Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 17 Apr 2026 · NCT07218913Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
Menerima pesertaFase 3
Usia 18 hingga 80 · Pria · Diperbarui 13 Feb 2026 · NCT06593665Germ Cell Tumor and Testicular Tumor DNA Registry
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT02099734Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Menerima peserta
Usia 18 hingga 39 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT06371768SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
Menerima peserta
Usia 18 hingga 39 · Pria · Diperbarui 1 Mei 2025 · NCT05836688Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.